The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases.
Interact Cardiovasc Thorac Surg
; 12(5): 824-6, 2011 May.
Article
en En
| MEDLINE
| ID: mdl-21297148
ABSTRACT
The reported benefits of intraoperative cell salvage are decreased requirement for blood transfusion and cost-effectiveness. This study was designed to challenge this hypothesis. We assessed intraoperative blood loss and the use of cell saver in our institution. In <7% of cases the volume of blood loss was sufficient enough to be washed and returned. We conclude that the routine use of cell savers in all cardiac operations affords no benefit and consumes additional revenue. We recommend that the system only be considered in selected high-risk cases or complex procedures.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Transfusión de Sangre Autóloga
/
Pérdida de Sangre Quirúrgica
/
Costos de Hospital
/
Recuperación de Sangre Operatoria
/
Procedimientos Quirúrgicos Cardíacos
Tipo de estudio:
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Interact Cardiovasc Thorac Surg
Asunto de la revista:
ANGIOLOGIA
/
CARDIOLOGIA
Año:
2011
Tipo del documento:
Article
País de afiliación:
Reino Unido